Zhiyong Wang
Founder & Chief Scientific Officer Venquis Therapeutics
Seminars
Wednesday 17th September 2025
Small Molecule Direct Degraders for Cancer Driver Proteins
11:30 am
- PI3Kalpha mutant and isoform specific degraders
- Positive selection screening strategy for KRAS G12D degraders
- Development of novel KRAS degraders
Wednesday 17th September 2025
Small Molecule Direct Degraders for Cancer Driver Proteins
2:00 pm
- PI3Kalpha mutant and isoform specific degraders
- Positive selection screening strategy for KRAS G12D degraders
- Development of novel KRAS degraders
